Anixa Biosciences, Inc. (ANIX)
3.265
-0.08
(-2.54%)
USD |
NASDAQ |
Sep 01, 16:00
3.265
0.00 (0.00%)
After-Hours: 19:29
Anixa Biosciences Total Long Term Debt (Quarterly) : 0.14M for April 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 0.14M |
| January 31, 2026 | 0.151M |
| October 31, 2025 | 0.163M |
| July 31, 2025 | 0.174M |
| April 30, 2025 | 0.184M |
| January 31, 2025 | 0.194M |
| October 31, 2024 | 0.203M |
| July 31, 2024 | 0.213M |
| April 30, 2024 | 0.093M |
| January 31, 2024 | 0.108M |
| October 31, 2023 | 0.123M |
| July 31, 2023 | 0.136M |
| April 30, 2023 | 0.149M |
| January 31, 2023 | 0.162M |
| October 31, 2022 | 0.175M |
| July 31, 2022 | 0.187M |
| April 30, 2022 | 0.202M |
| January 31, 2022 | 0.209M |
| October 31, 2021 | 0.2201M |
| July 31, 2021 | 0.00 |
| April 30, 2021 | 0.00 |
| January 31, 2021 | 0.00 |
| October 31, 2020 | 0.00 |
| July 31, 2020 | 0.0106M |
| April 30, 2020 | 0.026M |
| Date | Value |
|---|---|
| January 31, 2020 | 0.0408M |
| October 31, 2019 | 0.00 |
| July 31, 2019 | 0.00 |
| April 30, 2019 | 0.00 |
| January 31, 2019 | 0.00 |
| October 31, 2018 | 0.00 |
| July 31, 2018 | 0.00 |
| April 30, 2018 | 0.00 |
| January 31, 2018 | 0.00 |
| October 31, 2017 | 0.00 |
| July 31, 2017 | 0.00 |
| April 30, 2017 | 0.00 |
| January 31, 2017 | 4.313M |
| October 31, 2016 | 4.172M |
| July 31, 2016 | 3.688M |
| April 30, 2016 | 3.688M |
| January 31, 2016 | 0.00 |
| October 31, 2015 | 0.00 |
| July 31, 2015 | 0.00 |
| April 30, 2015 | 0.00 |
| January 31, 2015 | 0.00 |
| October 31, 2014 | 0.00 |
| July 31, 2014 | 1.756M |
| April 30, 2014 | 4.378M |
| January 31, 2014 | 2.18M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.371B |
| Oncolytics Biotech, Inc. | 0.31M |
| Sangamo Therapeutics, Inc. | 19.33M |
| Sarepta Therapeutics, Inc. | 1.046B |
| Vicapsys Life Sciences, Inc. | 0.00 |